ARTICLE | Finance
Alphamab's cancer cash
Alphamab Oncology to push several programs through the clinic with $100M A round
November 21, 2018 7:41 PM UTC
Alphamab Oncology spun out from Suzhou Alphamab Co. Ltd. and raised more than $100 million in a series A round to advance multiple cancer biologics through clinical testing.
Investors in the round, which closed on Nov. 17, include Advantech Capital, PAG, China Venture Capital Fund, OrbiMed Advisors, Heritage Provider Network and Janchor Partners...